Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight

New York, USA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight The Ebola virus market is focused on...
May 13, 2020 07:00 ET | Source: The Sabin Vaccine Institute

BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines

WASHINGTON, D.C. and ROME, Italy, May 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and...
January 16, 2018 09:00 ET | Source: GeoVax, Inc.

GeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports

ATLANTA, GA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its manuscript entitled “A...
January 20, 2016 19:13 ET | Source: AbCellera

AbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola Virus

VANCOUVER, British Columbia, Jan. 20, 2016 (GLOBE NEWSWIRE) -- AbCellera announced today successful completion of its first antibody discovery partnership with MassBiologics of the University...
August 05, 2014 08:35 ET | Source: MMRGlobal, Inc.

MMRGlobal to Grant Royalty-Free Licenses to Universities to Research Ebola Therapies Using Company's Patented Monoclonal Antibody Technology

LOS ANGELES, CA--(Marketwired - Aug 5, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that the Company plans on granting royalty-free licenses to universities interested in using the...